Antipsychotic Medchem Flashcards Preview

Pharmacy School 2016-17 > Antipsychotic Medchem > Flashcards

Flashcards in Antipsychotic Medchem Deck (22):

Q image thumb

First approved antipsychotic

SEs: Antimuscarinic (M1), Sedative (H1), Hypotensive (a1)


Phenothiazine Ring System = Photosensitivity


Q image thumb

Phenothiazine SAR


Position 2 is the best for substititurtion | the more electron withdrawing the better

Substitutions at positions 1 and 4 (1 more) decrease antipsychotic activity | unsubstituted phenothiazines have week antipsychotici activity

Three carbon chains connecting nitrogens is required (2 or 4 will decrease activity greatly)

Branching on the side chain with large groups will decrease activity (except for on gamma group)


On the basic nitrogen, tertiary amine group is the best, secondary not as good | anything more than di-methyl substitution starts to decrease activity | Piperidine and piperazine groups allowed | tertiary nitrogen required for passage through BBB but protonated ammonium has receptor activity


Q image thumb


Tri-fluoromethyl makes more potent than chlorpromazine | polar group off of piperazine contributes to antimuscarinic effects


Fluphenazine deconoate (ester formed at primary hydroxy to then be used in depot injections) | stays at site of infection and slowly released/hydrolyzed to active fluphenazine (3-4 weeks)


Q image thumb


R-enantiomer has higher affinity for D2 receptor (used as racemate)

CYP2D6 metabolism to sulfoxide metabolite (active) | do not use in CYP2D6 poor metabolizers

QT prolongation


Q image thumb


7-membered ring in the middle in place of central six-membered ring of phenothiazines

D4/D2 antagonist | 5HT2 antagonist


T1/2 = 12 hours | 1A2 (Major) 3A4 (minor) to N-desmethyl metabolite (may contribute to activity)


Risk of agranulocytosis | risk of reactive nitrenium ion formation which can react with GSH or protein nucleophiles, leading to toxicity


Q image thumb


No EWG | Thiophene isostere

T1/2 = 30 hours (dosed once daily) | N-demethylation (1A2) and 10-N-glucuronide are major metabolites


No agranulocytosis


Q image thumb

Olanzapine Pamoate (Pamoate ion)

Much less water soluble salt form | used in IM injectable formulation (2-4 weeks effective)


Q image thumb

Loxapine | Adasuve = inhalation powder

Not considered an atypical antipsychotic | still has EPS

3A4 metabolism (N-demethylation) to Amoxapine (active and blocks NE reuptake, antidperessant MOA)


Q image thumb

Quetiapine (atypical)

T1/2 = 7 hours

Branching group (top right) reduces antimuscarinic effects

Major metabolite is sulfoxide (3A4) | minor metabolite (3A4) is N-desalkylquetiapine (T1/2 = 12 hours; active but different profile) | D-desalkylquetiapine is potent M1 antagonist


Q image thumb

Asenapine | used as racemate

Central ring is no aromatic | minor catechol metabolite can be oxidized to reactive orthoquinone, leading to hypersensitivity (or arene oxide?)

T1/2 = 24 hours | Major metabolism is direct glucuronidation of 3 prime amine | minor is N-demethylation (1A2) | both inactive

No M1 antagonism (basic N is too close to ring system)

Weak 2D6 inhibitor


Q image thumb


T1/2 = 14-37 hours

High incidence of EPS | low antimuscarinic activity


Q image thumb

Haldol decanoate

Ester prodrug for depot injections | lasts up to 4 weeks

Metabolism (major): N-dealkylation (3A4/2D6), Reduction of ketone

Metabolism (minor): 3A4 to form MPP like toxic metabolite of MPTP (HPP+ metabolite = potential neurotoxicities)


Q image thumb


CYP2D6 metabolism is the major enzyme | T1/2 = 3 hours (EM), T1/2 = 20 hours (PM)


Metabolism to Paliperidone


Q image thumb

Paliperidone | 9-hydroxyrisperidone | Invega Sustenna = Paliperidone palmitate (16 C) = ester prodrug for depot injections


T1/2 = 23 hours


Active metabolite of risperidone | available as separate drug

No major role for 2D6 metabolism (no major routes) | 60% excreted unchanged


Q image thumb


Identical side group to risperidone

T1/2 = 18 hours (EM), T1/2 = 33 hours (PM)

Metabolism: Reduction of ketone (active), 2D6 hydroxylation (active), 3A4 O-demethylation (inactive)


*recommended to decrease dose if taking strong 2D6/3A4 inhibitors


Q image thumb


T1/2 = 7 hours

All major group are isosteres of the features of risperidone

3A4 (1A2) metabolism to sulfoxide and sulfone meatbolites and N-dealkylation (inactive) | P450 metabolism accounts for 1/3 overall

Aldeyhyde oxidase (2/3 of metabolism) alpha reduction followed by s-methylation

*Cimetidine has no effect


Q image thumb


Same side group as ziprasidone

Used as single enantiomer | T1/2 = 18 hours

CYP3A4 = major enzyme --> Sulfoxide/sulfone matabolites (inactive)

Hydroxylation to active metabolites (contribute to overall activity)

N-dealkylation to inactive metabolite


Q image thumb


T1/2 = 75 hours (EM), T1/2 = 146 hours (PM)

Slightly longer spacer between structural elements

D2 partial agonist

2D6 and 3A4 are key enzymes involved in metabolism | dehydroariprazole is active but less potent (T1/2 = 94 hours)


Q image thumb

Aripiprazole lauroxil (C12)

Esterase and spontaneous elimination of water gives active

Lipophilic prodrug for IM injections | Once monthly or once every 6 weeks


Q image thumb


Benzothiophene group (vs dichlorobenzene in aripirazole)

D2 partial agonist (also actions at 5HT2 receptors)

2D6 and 3A4 to inactive metabolites

T1/2 = 91 hours


Q image thumb


T1/2 = 2-4 days

D3/D2 partial agonist

3A4 (2D6 minor) to desmethyl and didesmethyl metabolites (both active and approximately equipotent) and T1/2 = 1-3 weeks


Q image thumb


T1/2 = 57 hours

Used to treeat Parkinson's associated psychoses | Acts at 5HT2 receptors


CYP3A4 to N-desmethyl metabolite (Active w/ T1/2 = 200 hours)